Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares for the month of April 2026. The filing details a share repurchase executed on April 7, 2026, pursuant to a non-discretionary agreement with BNP Paribas SA, originally announced on February 17, 2026.
Key Financial Metrics
The filing focuses exclusively on capital allocation activities regarding the Company's share buyback program. No revenue, profit, cash flow, or debt metrics are disclosed in this specific document.
- Shares Purchased (April 7, 2026): 335,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 2,084.00p; highest price paid was 2,134.00p.
- Volume-Weighted Average Price (VWAP): 2,113.08p.
- Trading Venues: Purchases were executed across XLON (London Stock Exchange), CHIX, and BATE.
- Treasury Shares Held: 257,127,615 ordinary shares (post-transaction).
- Shares in Issue: 4,059,056,834 ordinary shares (excluding Treasury shares).
- Treasury Voting Rights: 6.33% of total voting rights.
Material Changes
Since the commencement of the current buyback agreement on February 17, 2026, the Company has purchased an aggregate of 17,236,521 ordinary shares. The transaction reported herein represents the latest execution under this program, increasing the total treasury holding to 257,127,615 shares.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, operational outlook, or management commentary regarding business performance. It includes a standard cautionary statement noting that forward-looking statements are subject to risks and uncertainties, referencing the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2025.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback program since February 17, 2026 (17,236,521).
- Confirm the updated treasury share count (257,127,615) and its impact on the percentage of voting rights (6.33%).
- Review the specific trading venues (XLON, CHIX, BATE) and the VWAP of 2,113.08p for the April 7 transaction.
- Check the total number of voting rights (4,059,056,834) for disclosure threshold calculations under FCA rules.